118 related articles for article (PubMed ID: 37972856)
1. Circulating tumor necrosis factor-related biomarkers predict kidney function decline in Japanese patients with diabetes: An observational cohort study.
Murakoshi M; Kamei N; Suzuki Y; Kubota M; Sanuki M; Tashiro H; Iwasawa T; Kato K; Tanaka M; Furuhashi M; Gohda T
Diabetes Res Clin Pract; 2023 Dec; 206():111017. PubMed ID: 37972856
[TBL] [Abstract][Full Text] [Related]
2. Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study.
Gutiérrez OM; Shlipak MG; Katz R; Waikar SS; Greenberg JH; Schrauben SJ; Coca S; Parikh CR; Vasan RS; Feldman HI; Kimmel PL; Cushman M; Bonventre JV; Sarnak MJ; Ix JH
Am J Kidney Dis; 2022 Jun; 79(6):849-857.e1. PubMed ID: 34752914
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal TNFR1 and TNFR2 and Kidney Outcomes: Results from AASK and VA NEPHRON-D.
Chen TK; Coca SG; Estrella MM; Appel LJ; Coresh J; Thiessen Philbrook H; Obeid W; Fried LF; Heerspink HJL; Ix JH; Shlipak MG; Kimmel PL; Parikh CR; Grams ME;
J Am Soc Nephrol; 2022 May; 33(5):996-1010. PubMed ID: 35314457
[TBL] [Abstract][Full Text] [Related]
4. Circulating Tumor Necrosis Factor α Receptors Predict the Outcomes of Human IgA Nephropathy: A Prospective Cohort Study.
Oh YJ; An JN; Kim CT; Yang SH; Lee H; Kim DK; Joo KW; Paik JH; Kang SW; Park JT; Lim CS; Kim YS; Lee JP
PLoS One; 2015; 10(7):e0132826. PubMed ID: 26177311
[TBL] [Abstract][Full Text] [Related]
5. Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.
Gohda T; Niewczas MA; Ficociello LH; Walker WH; Skupien J; Rosetti F; Cullere X; Johnson AC; Crabtree G; Smiles AM; Mayadas TN; Warram JH; Krolewski AS
J Am Soc Nephrol; 2012 Mar; 23(3):516-24. PubMed ID: 22266664
[TBL] [Abstract][Full Text] [Related]
6. Association between circulating tumor necrosis factor-related biomarkers and estimated glomerular filtration rate in type 2 diabetes.
Kamei N; Yamashita M; Nishizaki Y; Yanagisawa N; Nojiri S; Tanaka K; Yamashita Y; Shibata T; Murakoshi M; Suzuki Y; Gohda T
Sci Rep; 2018 Oct; 8(1):15302. PubMed ID: 30333553
[TBL] [Abstract][Full Text] [Related]
7. Fractional excretion of tumor necrosis factor receptor 1 and 2 in patients with type 2 diabetes and normal renal function.
Gohda T; Kamei N; Kubota M; Tanaka K; Yamashita Y; Sakuma H; Kishida C; Adachi E; Koshida T; Murakoshi M; Hagiwara S; Funabiki K; Ueda S; Suzuki Y
J Diabetes Investig; 2021 Mar; 12(3):382-389. PubMed ID: 32643269
[TBL] [Abstract][Full Text] [Related]
8. TNFR2 as a Potential Biomarker for Early Detection and Progression of CKD.
Lousa I; Reis F; Viana S; Vieira P; Vala H; Belo L; Santos-Silva A
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979469
[TBL] [Abstract][Full Text] [Related]
9. Association between graft function and serum TNF-α, TNFR1 and TNFR2 levels in patients with kidney transplantation.
Budak D; Yilmaz VT; Akbas H; Suleymanlar G; Yucel G
Ren Fail; 2015 Jun; 37(5):871-6. PubMed ID: 25707514
[TBL] [Abstract][Full Text] [Related]
10. Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Schrauben SJ; Shou H; Zhang X; Anderson AH; Bonventre JV; Chen J; Coca S; Furth SL; Greenberg JH; Gutierrez OM; Ix JH; Lash JP; Parikh CR; Rebholz CM; Sabbisetti V; Sarnak MJ; Shlipak MG; Waikar SS; Kimmel PL; Vasan RS; Feldman HI; Schelling JR;
J Am Soc Nephrol; 2021 Jan; 32(1):115-126. PubMed ID: 33122288
[TBL] [Abstract][Full Text] [Related]
11. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.
Barr ELM; Barzi F; Hughes JT; Jerums G; Hoy WE; O'Dea K; Jones GRD; Lawton PD; Brown ADH; Thomas M; Ekinci EI; Sinha A; Cass A; MacIsaac RJ; Maple-Brown LJ
Diabetes Care; 2018 Apr; 41(4):739-747. PubMed ID: 29367427
[TBL] [Abstract][Full Text] [Related]
12. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.
Niewczas MA; Gohda T; Skupien J; Smiles AM; Walker WH; Rosetti F; Cullere X; Eckfeldt JH; Doria A; Mayadas TN; Warram JH; Krolewski AS
J Am Soc Nephrol; 2012 Mar; 23(3):507-15. PubMed ID: 22266663
[TBL] [Abstract][Full Text] [Related]
13. Circulating TNF receptor levels are associated with estimated glomerular filtration rate even in healthy individuals with normal kidney function.
Gohda T; Murakoshi M; Shibata T; Suzuki Y; Takemura H; Tsuchiya K; Okada T; Wakita M; Horiuchi Y; Tabe Y; Kamei N
Sci Rep; 2024 Mar; 14(1):7245. PubMed ID: 38538662
[TBL] [Abstract][Full Text] [Related]
14. Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.
Pavkov ME; Nelson RG; Knowler WC; Cheng Y; Krolewski AS; Niewczas MA
Kidney Int; 2015 Apr; 87(4):812-9. PubMed ID: 25272234
[TBL] [Abstract][Full Text] [Related]
15. Circulating TNF Receptors 1 and 2 Predict Mortality in Patients with End-stage Renal Disease Undergoing Dialysis.
Gohda T; Maruyama S; Kamei N; Yamaguchi S; Shibata T; Murakoshi M; Horikoshi S; Tomino Y; Ohsawa I; Gotoh H; Nojiri S; Suzuki Y
Sci Rep; 2017 Mar; 7():43520. PubMed ID: 28256549
[TBL] [Abstract][Full Text] [Related]
16. High levels of circulating TNFR1 increase the risk of all-cause mortality and progression of renal disease in type 2 diabetic nephropathy.
Fernández-Juárez G; Villacorta Perez J; Luño Fernández JL; Martinez-Martinez E; Cachofeiro V; Barrio Lucia V; Tato Ribera AM; Mendez Abreu A; Cordon A; Oliva Dominguez JA; Praga Terente M
Nephrology (Carlton); 2017 May; 22(5):354-360. PubMed ID: 27003829
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor necrosis factor receptors are associated with mortality and disease severity in COVID-19 patients.
Gohda T; Murakoshi M; Suzuki Y; Hiki M; Naito T; Takahashi K; Tabe Y
PLoS One; 2022; 17(10):e0275745. PubMed ID: 36219652
[TBL] [Abstract][Full Text] [Related]
18. Validating the association between plasma tumour necrosis factor receptor 1 levels and the presence of renal injury and functional decline in patients with Type 2 diabetes.
Doody A; Jackson S; Elliott JA; Canavan RJ; Godson C; Slattery D; Twomey PJ; McKenna MJ; le Roux CW; Docherty NG
J Diabetes Complications; 2018 Jan; 32(1):95-99. PubMed ID: 29122448
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study.
Inaguma D; Imai E; Takeuchi A; Ohashi Y; Watanabe T; Nitta K; Akizawa T; Matsuo S; Makino H; Hishida A;
Clin Exp Nephrol; 2017 Jun; 21(3):446-456. PubMed ID: 27412450
[TBL] [Abstract][Full Text] [Related]
20. Plasma Biomarkers of Tubular Injury and Inflammation Are Associated with CKD Progression in Children.
Greenberg JH; Abraham AG; Xu Y; Schelling JR; Feldman HI; Sabbisetti VS; Gonzalez MC; Coca S; Schrauben SJ; Waikar SS; Ramachandran VS; Shlipak MG; Warady B; Kimmel PL; Bonventre JV; Denburg M; Parikh CR; Furth S;
J Am Soc Nephrol; 2020 May; 31(5):1067-1077. PubMed ID: 32234829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
